title: Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.
abstract: Alternative polyadenylation (APA), which induces shortening of the 3'UTR, is emerging as an important phenomenon in gene regulation. APA is involved in development, cancer and cell proliferation. APA may lead to disruption of microRNA-mediated gene silencing in cancer cells via detachment of microRNA binding sites. We studied the correlation between the APA profile and the tumor aggressiveness in cases of lung cancer. We selected the top 10 genes showing significant 3'UTR shortening in lung cancer, using the package of the Bioconductor for probe-level analyses of expression microarrays. We established and evaluated the APA score by quantitative RT-PCR in 147 clinical specimens of non-small cell lung cancer and compared the results with the clinical outcomes and expression levels of APA-related genes, including PABPN1, CPEB1, E2F1 and proliferation markers (MKI67, TOP2A and MCM2). High APA scores were correlated with an advanced tumor stage and a poor prognosis (P < 0.001). Multivariate analysis identified the APA score as an independent prognostic factor (hazard ratio, 3.0; P = 0.03). Both lower expression of PABPN1 and higher expression of the proliferation markers were correlated with high APA scores and a poor prognosis, with suppression of PABPN1 exerting its influence independent of gain of the proliferation markers. Moreover, the APA score was correlated with the maximum standardized uptake value of the tumors on positron emission tomography (r = 0.53; P < 0.001). Our results indicate that the loss of PABPN1, a suppressor of APA, might promote tumor aggressiveness by releasing the cancer cells from microRNA-mediated gene regulation.
authors: Department of Thoracic Surgery, University of Tokyo Hospital, Tokyo, Japan.
authors: Junji
authors: J
authors: Ichinose
authors: Kousuke
authors: K
authors: Watanabe
authors: Atsushi
authors: A
authors: Sano
authors: Takahide
authors: T
authors: Nagase
authors: Jun
authors: J
authors: Nakajima
authors: Masashi
authors: M
authors: Fukayama
authors: Yutaka
authors: Y
authors: Yatomi
authors: Nobuya
authors: N
authors: Ohishi
authors: Daiya
authors: D
authors: Takai
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D005260:Female; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D053208:Kaplan-Meier Estimate; D008175:Lung Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D008297:Male; D035683:MicroRNAs / Q000502:physiology; D039122:Poly(A)-Binding Protein I / Q000235:genetics* / Q000378:metabolism; D026723:Polyadenylation; D011379:Prognosis; D034622:RNA Interference
chemical_list: D035683:MicroRNAs; C576588:PABPN1 protein, human; D039122:Poly(A)-Binding Protein I
keywords: Alternative polyadenylation; PABPN1; lung cancer; prognosis; rmodel